Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,170.00
Bid: 12,172.00
Ask: 12,174.00
Change: 108.00 (0.90%)
Spread: 2.00 (0.016%)
Open: 12,194.00
High: 12,266.00
Low: 12,054.00
Prev. Close: 12,062.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WRAPUP 7-Europe rolls out 'new weapon' vaccines in bid to slay COVID

Sun, 27th Dec 2020 20:01

* Goal is to offer vaccine to all adults through 2021

* 'Thank God,' says first recipient in Spain, 96

* Delays in some German cities over cooling concerns

* Urgency as new virus variants crop up

By Isla Binnie and Giselda Vagnoni

MADRID/ROME, Dec 27 (Reuters) - Europe launched a mass
COVID-19 vaccination drive on Sunday with pensioners and medics
lining up to get the first shots to see off a pandemic that has
crippled economies and claimed more than 1.7 million lives
worldwide.

"Thank God," 96-year-old Araceli Hidalgo said as she became
the first person in Spain to have a vaccine at her care home in
Guadalajara, near the capital Madrid.

"Let's see if we can make this virus go away."

In Italy, the first country in Europe to record significant
numbers of infections, 29-year-old nurse Claudia Alivernini was
one of three medical staff at the head of the queue for the shot
developed by Pfizer and BioNTech.

"It is the beginning of the end ... it was an exciting,
historic moment," she said at Rome's Spallanzani hospital.

The region of 450 million people is trying to catch up with
the United States and Britain, which have already started
vaccinations using the Pfizer shot.

The European Union is due to receive 12.5 million doses by
the end of the year, enough to vaccinate 6.25 million people
based on the two-dose regimen. The companies are scrambling to
meet global demand and aim to make 1.3 billion shots next year.

The bloc has secured contracts with a range of drugmakers
besides Pfizer, including Moderna and AstraZeneca
, for a total of more than two billion vaccine doses and
has set a goal for all adults to be inoculated during 2021.

With surveys pointing to high levels of hesitancy towards
the vaccine in countries from France to Poland, leaders of the
27-country European Union are promoting it as the best chance of
getting back to something like normal life next year.

"We have a new weapon against the virus: the vaccine. We
must stand firm, once more," tweeted French President Emmanuel
Macron, who tested positive for the coronavirus this month and
left quarantine on Christmas Eve.

But Ireneusz Sikorski, 41, leaving church in the Polish
capital of Warsaw, was sceptical.

"I don't think there's a vaccine in history that has been
tested so quickly," he said. "I am not saying vaccination
shouldn't be taking place. But I am not going to test an
unverified vaccine on my children, or on myself."

COOLING CONCERNS

Distribution of the shot presents tough challenges as the
vaccine uses new mRNA technology and must be stored at about -70
degrees Celsius (-112°F).

In Germany, the campaign faced delays in several cities
after a temperature tracker showed that about 1,000 shots may
not have been kept cold enough during transit.

BioNtech said it was responsible for the shipment to the 25
German distribution centres and that the federal states and
local authorities were responsible for the shipment to the
vaccination centres and the mobile vaccination teams.

"This is where the variations in temperature occurred. We
are in contact with many authorities to provide advice, however
it is up to them how to proceed", a spokeswoman said.

The Pfizer shots being used in Europe were shipped from its
factory in Puurs, Belgium, in specially designed containers
filled with dry ice. They can be stored for up to six months at
Antarctic winter temperatures, or for five days at 2C to 8C, a
type of refrigeration commonly available at hospitals.

In Italy, temporary solar-powered healthcare pavilions
designed to look like five-petalled primrose flowers - a symbol
of spring - sprouted in town squares as the vaccination drive
kicked off.

Portugal has been establishing separate cold storage units
for its Atlantic archipelagos of Madeira and the Azores.

At the Santa Maria hospital in Portugal's capital Lisbon,
Pedro Pires waited for a shot with other nurses at the end of an
overnight shift.

"It has been tiring," he told Reuters.

Branka Anicic, an 81-year-old resident of a care home in
Zagreb, became the first person to get a shot in Croatia. "I'm
happy I will now be able to see my great-grandchildren," she
said.

German pilot Samy Kramer celebrated the vaccination campaign
by tracing out a giant syringe in the sky. He flew 200 km (125
miles), following a syringe-shaped route that showed up on
internet site flightradar24.

'FIRST MAN ON THE MOON'

The vaccination drive is all the more urgent because of the
concern around new variants of the virus linked to a rapid
expansion of cases in Britain and South Africa.

"We know that the pandemic won't just disappear as of today,
but the vaccine is the beginning of the victory over the
pandemic, the vaccine is a 'game changer'," said Austrian
Chancellor Sebastian Kurz.

Cases of the UK variant have been detected in Australia,
Hong Kong and in Europe, mostly recently in Sweden, France,
Norway and Portugal's island of Madeira. So far, scientists say
there is no evidence to suggest the vaccines developed will be
any less effective against the new variants.

While Europe has some of the best-resourced healthcare
systems in the world, the scale of the effort means some
countries are calling on retired medics to help while others
have loosened rules for who is allowed to give the injections.

Beyond hospitals and care homes, sports halls and convention
centres left vacant by lockdown restrictions will become venues
for mass inoculations.

Vaccinations also started in Norway, which is not a member
of the EU bloc.

"I feel like a historical figure ... almost like the first
man on the Moon," said care home resident Svein Andersen, 67, as
he received the country's first shot in the capital, Oslo.

After European governments were criticised for failing to
work together to counter the spread of the virus in early 2020,
the goal this time is to ensure that there is equal access
across the region.

But even then, Hungary on Saturday jumped the gun on the
official roll-out by administering shots to frontline workers at
hospitals in the capital Budapest. The Netherlands said it will
not start vaccinating until Jan. 8.

Slovakia also went ahead with some inoculations of
healthcare staff on Saturday and in Germany, a small number of
people at a care home were inoculated a day early too.

"We don't want to waste that one day that the vaccine loses
shelf life," Karsten Fischer, from the pandemic staff of the
Harz district in the German state of Saxony-Anhalt, told
broadcaster MDR.

(Additional reporting by Catarina Demony in Lisbon, Silke
Koltrowitz in Vienna, Robert Muller in Prague, Tsvetelia Tsolova
in Sofia, Igor Ilic in Zagreb, Nerijus Adomaitis in oslo,
Michele Kambas in Athens and Benoit Van Overstraeten in Paris;
Writing by Mark John and Andrew Heavens; Editing by David Clarke
and Nick Macfie)

More News
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more
25 Apr 2024 07:56

REPEAT: Miner Anglo American reviews takeover bid from rival BHP

(Alliance News) - Stocks in London are called to open slightly higher, after a busy start to the day, with corporate earnings and updates.

Read more
25 Apr 2024 07:52

Sanofi profit slips on generic competition and currency effects

April 25 (Reuters) - Sanofi's first-quarter operating income fell 14.7% as currency effects and cheap competition to its multiple sclerosis drug Aubagio outweighed rising sales of anti-inflammatory drug Dupixent, the French drugmaker said on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.